Pharmaceutical pricing, cost containment and new treatments for rare diseases in children

by Stella, Peter, Gold-von Simson, Gabrielle
Published 2014

Safety, tolerability and effects on cardiometabolic risk factors of empagliflozin monotherapy in drug-naïve patients with type 2 diabetes: a double-blind extension of a Phase III r...

by Roden, Michael, Merker, Ludwig, Christiansen, Anita Vedel, Roux, Flavien, Salsali, Afshin, Kim, Gabriel, Stella, Peter, Woerle, Hans J., Broedl, Uli C.
Published 2015